KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:OCRX
Delisted

Ocera Therapeutics Fund Forecast

$1.79
+0 (+0%)
At Close: Jan 16, 2018
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Red day on Tuesday for Ocera Therapeutics
(Updated on Jan 16, 2018)

Buy or Hold candidate since Nov 02, 2017 Gain 4.07% PDF

No changes to the price of Ocera Therapeutics fund on the last trading day (Tuesday, 16th Jan 2018). During the last trading day the fund fluctuated 0% from a day low at $1.79 to a day high of $1.79. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The fund lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the fund is expected to rise 44.58% during the next 3 months and, with a 90% probability hold a price between $2.29 and $3.31 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

OCRX Signals & Forecast

The Ocera Therapeutics fund holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.79 and $1.78. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, January 15, 2018, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Ocera Therapeutics fund

Ocera Therapeutics finds support from accumulated volume at $1.72 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the fund tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the fund During the last day, the fund moved $0 between high and low, or 0%. For the last week the fund has had daily average volatility of 0%

Our recommended stop-loss: $1.72 (-4.00%) (This fund has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (OCRX) For The Upcoming Trading Day Of Wednesday 17th

For the upcoming trading day on Wednesday, 17th we expect Ocera Therapeutics to open at $1.79, and during the day (based on 14 day Average True Range), to move between $1.78 and $1.80, which gives a possible trading interval of +/-$0.0083 (+/-0.46%) up or down from last closing price. If Ocera Therapeutics takes out the full calculated possible swing range there will be an estimated 0.93% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $1.72, some $0.0700 (3.91%) from the current price of $1.79, our system finds the risk reward attractive.

Is Ocera Therapeutics fund A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Ocera Therapeutics fund to perform well in the short-term.

Current score: 1.477 Buy Candidate Unchanged

Predicted Opening Price for Ocera Therapeutics of Wednesday, January 17, 2018

Fair opening price January 17, 2018 Current price
$1.79 ( 0%) $1.79

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for OCRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.79 .
R2 1.79 .
R1 1.79 .
Current price: 1.79
Support S1 1.79 .
S2 1.79 .
S3 1.79 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 1.79
Support S1 1.72 -3.91%
S2 1.70 -5.03%
S3 1.69 -5.59%

FAQ

What is the symbol for Ocera Therapeutics Fund and on which exchange is it traded?
The symbol for Ocera Therapeutics is OCRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ocera Therapeutics Fund?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Ocera Therapeutics fund to perform well in the short-term.

How to buy Ocera Therapeutics Fund?
Ocera Therapeutics Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ocera Therapeutics Fund.

What's the current price of Ocera Therapeutics Fund?
As of the end of day on the Jan 16, 2018, the price of an Ocera Therapeutics (OCRX) share was $1.79.

What is the 52-week high and low for Ocera Therapeutics Fund?
The 52-week high for Ocera Therapeutics Fund is $2.24 and the 52-week low is $0.520.
Click to get the best stock tips daily for free!

About Ocera Therapeutics

Ocera Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the development and commercialization of OCR-002, which is in Phase IIb trials for the treatment of hyperammonemia and hepatic encephalopathy in patients with liver cirrhosis, acute liver injury, and acute liver failure, as well as in the areas of unmet medical need. The company is headquartered in Palo Alto, California.... OCRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT